Literature DB >> 15726247

No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis.

Stefan Kastenbauer, Bernd C Kieseier, Bernhard F Becker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15726247     DOI： 10.1007/s00415-005-0697-z

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Nonenzymatic antioxidants of blood in multiple sclerosis.

Authors:  E Karg; P Klivényi; I Németh; K Bencsik; S Pintér; L Vécsei
Journal:  J Neurol       Date:  1999-07       Impact factor: 4.849

2.  Oxidative stress in bacterial meningitis in humans.

Authors:  S Kastenbauer; U Koedel; B F Becker; H W Pfister
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

3.  Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins.

Authors:  S Spitsin; D C Hooper; T Mikheeva; H Koprowski
Journal:  Mult Scler       Date:  2001-06       Impact factor: 6.312

4.  Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction.

Authors:  G Toncev; B Milicic; S Toncev; G Samardzic
Journal:  Eur J Neurol       Date:  2002-05       Impact factor: 6.089

5.  Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis.

Authors:  D C Hooper; S Spitsin; R B Kean; J M Champion; G M Dickson; I Chaudhry; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

6.  Uric acid levels in sera from patients with multiple sclerosis.

Authors:  J Drulović; I Dujmović; N Stojsavljević; S Mesaros; S Andjelković; D Miljković; V Perić; G Dragutinović; J Marinković; Z Lević; M Mostarica Stojković
Journal:  J Neurol       Date:  2001-02       Impact factor: 4.849

7.  Serum uric acid and multiple sclerosis.

Authors:  S Sotgiu; M Pugliatti; A Sanna; A Sotgiu; M L Fois; G Arru; G Rosati
Journal:  Neurol Sci       Date:  2002-10       Impact factor: 3.307

Review 8.  The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy.

Authors:  Yossi Gilgun-Sherki; Eldad Melamed; Daniel Offen
Journal:  J Neurol       Date:  2004-03       Impact factor: 4.849
  8 in total
  6 in total

1.  Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.

Authors:  Maira Gironi; Bruno Borgiani; Enrica Mariani; Cristina Cursano; Laura Mendozzi; Rossella Cavarretta; Marina Saresella; Mario Clerici; Giancarlo Comi; Marco Rovaris; Roberto Furlan
Journal:  J Immunol Res       Date:  2014-03-26       Impact factor: 4.818

2.  Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis.

Authors:  Carmen Martínez; Elena García-Martín; Julián Benito-León; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecilla; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  Neuromolecular Med       Date:  2009-10-14       Impact factor: 3.843

Review 3.  Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.

Authors:  Genaro G Ortiz; Fermín P Pacheco-Moisés; Oscar K Bitzer-Quintero; Ana C Ramírez-Anguiano; Luis J Flores-Alvarado; Viridiana Ramírez-Ramírez; Miguel A Macias-Islas; Erandis D Torres-Sánchez
Journal:  Clin Dev Immunol       Date:  2013-09-24

4.  NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.

Authors:  José A G Agúndez; Elena García-Martín; Carmen Martínez; Julián Benito-León; Jorge Millán-Pascual; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Laura Turpín-Fenoll; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecillas; José Francisco Plaza-Nieto; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2014-04-23       Impact factor: 2.474

5.  Increased Cerebrospinal Fluid Uric Acid Levels in Guillain-Barré Syndrome.

Authors:  Sheng-Hui Chang; Xiao-Bing Tian; Jing Wang; Ming-Qi Liu; Chen-Na Huang; Yuan Qi; Lin-Jie Zhang; Chun-Li Gao; Da-Qi Zhang; Li-Sha Sun; Li Yang
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

6.  Mendelian randomization study shows no causal effects of serum urate levels on the risk of MS.

Authors:  Adil Harroud; J Brent Richards; Sergio E Baranzini
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-11-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.